40243 |
Oncology |
Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluoroura... |
J CANCER 2021 10.7150/jca.49176 |
박영석 |
2021 |
40242 |
Oncology |
Clinical sequencing to assess tumor mutational burden as a useful biom... |
THER ADV MED ONCOL 2021 10.1177/1758835921992992 |
박영석 |
2021 |
40241 |
Medicine, Research & Experimental |
ATM Expression as a Prognostic Marker in Patients With Advanced Biliar... |
IN VIVO 2021 10.21873/invivo.12284 |
박영석 |
2021 |
40240 |
Oncology |
A randomized phase III trial comparing adjuvant single-agent S1, S-1 w... |
ANN ONCOL 2021 10.1016/j.annonc.2020.11.017 |
박영석 |
2021 |
40239 |
Oncology; Pharmacology & Pharmacy |
A phase 1 dose-escalation and dose-expansion study to assess the safet... |
INVEST NEW DRUG 2021 10.1007/s10637-021-01110-9 |
박영석 |
2021 |
40238 |
Oncology |
The Role of Chemotherapy in Patients With HER2-Negative Isolated Locor... |
FRONT ONCOL 2021 10.3389/fonc.2021.653243 |
박연희 |
2021 |
40237 |
Medicine, General & Internal |
Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Sing... |
DIAGNOSTICS 2021 10.3390/diagnostics11020370 |
박연희 |
2021 |
40236 |
Oncology |
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Pl... |
CLIN CANCER RES 2021 10.1158/1078-0432.CCR-20-1008 |
박연희 |
2021 |
40235 |
Oncology |
Prognostic Factors for Overall Survival in Patients with Hormone Recep... |
ONCOLOGIST 2021 10.1002/onco.13833 |
박연희 |
2021 |
40234 |
Biochemistry & Molecular Biology; Cell Biology; Immunology |
Prognostic effects of cytokine levels on patients treated with taxane ... |
CYTOKINE 2021 10.1016/j.cyto.2021.155487 |
박연희 |
2021 |